Our analysis revealed an overall trend of increased m6A regulator expression in pancreatic cancer (Supplementary Fig.
← all excerpts
TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of Anti-PD-1 immunotherapy.
1
—
—